Search
Dianthus Therapeutics Inc
DNTHAdd to Watchlist
86.030USD
+3.020+3.64%
Close 11-06 16:00（ET）
4.81BMarket Cap
LossP/E TTM
DNTH Financials
See Dianthus Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
4.81B
Dividend TTM
0.00
P/E TTM
-20.32
EPS TTM
-4.23
Revenue
2.04M
Net Profit
-84.97M
ROE
-22.70%
ROA
-21.77%
Dianthus Therapeutics Inc Earnings Date
Latest Release
Nov 4, 2026
EPS / Forecast
-0.81/-0.98
Revenue / Forecast
1.21M/444.64K
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
Revenue
By Business
Period:
No Data
By Region
Period:No Data
FAQs
What is the total revenue of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2025 earnings report, its total revenue reached 2.04M, with a year-on-year change of 6.23M.
What are the current assets of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2025 earnings report, its current assets were 409.44M, with a year-on-year change of 45.76.
What are the total assets of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2025 earnings report, its total assets of Dianthus Therapeutics Inc were 530.92M, with a year-on-year change of 41.95.
What are the total liabilities of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2025 earnings report, its total liabilities of Dianthus Therapeutics Inc were 37.52M, with a year-on-year change of 74.27.
What is the total equity of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2025 earnings report, its total equity of Dianthus Therapeutics Inc was 493.40M, with a year-on-year change of 39.98.
What is the net operating income of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2025 earnings report, its net operating income of Dianthus Therapeutics Inc was -177.93M, with a year-on-year change of -74.68.
What is the net investment of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2025 earnings report, its net investment of Dianthus Therapeutics Inc was -122.83M, with a year-on-year change of 57.17.
What is the net financing of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2025 earnings report, its net financing of Dianthus Therapeutics Inc was 280.12M, with a year-on-year change of 9.59.
What is the Earnings Per Share (EPS) of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.20, with a year-on-year change of -64.82.
What is the net income of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2025 earnings report, its net income was -162.34M, with a year-on-year change of -91.05.
What is the net margin of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2025 earnings report, its net profit margin was -7973.33, with a year-on-year change of -485.08.
What is the Return on Equity (ROE) of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -38.38, with a year-on-year change of -17.75.
What is the Return on Assets (ROA) of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -35.88, with a year-on-year change of -16.84.
What is the operating profit of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2025 earnings report, its operating profit was -177.93M, with a year-on-year change of -74.68.